Biohit Oyj (OHEL:BIOBV) Cash-to-Debt : 9.71 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Biohit Oyj's cash to debt ratio for the quarter that ended in Dec. 2023 was 9.71.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Biohit Oyj could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Biohit Oyj's Cash-to-Debt or its related term are showing as below:

OHEL:BIOBV' s Cash-to-Debt Range Over the Past 10 Years
Min: 6.6 Med: 36.59 Max: No Debt
Current: 9.71

During the past 13 years, Biohit Oyj's highest Cash to Debt Ratio was No Debt. The lowest was 6.60. And the median was 36.59.

OHEL:BIOBV's Cash-to-Debt is ranked better than
55.49% of 1539 companies
in the Biotechnology industry
Industry Median: 6.51 vs OHEL:BIOBV: 9.71

Biohit Oyj Cash-to-Debt Historical Data

The historical data trend for Biohit Oyj's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Biohit Oyj Cash-to-Debt Chart

Biohit Oyj Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

32.48

15.96

24.96

6.60

9.71

Biohit Oyj Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															24.96	5.27	6.60	7.00	9.71

Competitive Comparison of Biohit Oyj's Cash-to-Debt

For the Biotechnology subindustry, Biohit Oyj's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biohit Oyj's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's Cash-to-Debt falls into.

Biohit Oyj Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Biohit Oyj's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	6.814	/	(0.275	+	0.427)
	=	9.71

Biohit Oyj's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	6.814	/	(0.275	+	0.427)
	=	9.71

Biohit Oyj (OHEL:BIOBV) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Biohit Oyj Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biohit Oyj (OHEL:BIOBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Laippatie 1, Helsinki, FIN, 00880

Website

https://www.biohithealthcare.com

Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines